News | October 31, 2023
Sun Pharma to co-market Zydus’s CKD treatment drug ‘Desidustat’ in India
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
This inspection is the fourth major regulatory inspection (after Russia, Canada and Brazil), cleared by this site in the past two years
Diofan Ultra736 provides ultra-high water vapor barrier with excellent thermoformability, unlocking the potential to design thinner and more sustainable blister films
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
Subscribe To Our Newsletter & Stay Updated
